NDC 57894-450

TECVAYLI

Teclistamab

TECVAYLI is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is Teclistamab.

Product ID57894-450_a84eedd6-8108-11eb-b7ff-e2fefb2ca371
NDC57894-450
Product TypeHuman Prescription Drug
Proprietary NameTECVAYLI
Generic NameTeclistamab
Dosage FormInjection
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2022-10-25
Marketing CategoryBLA /
Application NumberBLA761291
Labeler NameJanssen Biotech, Inc.
Substance NameTECLISTAMAB
Active Ingredient Strength90 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 57894-450-01

1 VIAL, SINGLE-DOSE in 1 CARTON (57894-450-01) > 1.7 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-10-25
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "TECVAYLI" or generic name "Teclistamab"

NDCBrand NameGeneric Name
57894-449TECVAYLIteclistamab
57894-450TECVAYLIteclistamab

Trademark Results [TECVAYLI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TECVAYLI
TECVAYLI
90798805 not registered Live/Pending
Johnson & Johnson
2021-06-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.